Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Three gallium(III)- and thallium(III)-containing polyoxopalladates (POPs) have been synthesized and structurally characterized in the solid state and in solution, namely, the phosphate-capped 12-palladate nanocubes [XPdO(PO)] (X = Ga, ; X = Tl, ) and the 23-palladate double-cube [TlPdPO(OH)] (). The cuboid POPs, and , are solution stable as verified by the respective P, Ga, and Tl nuclear magnetic resonance (NMR) spectra. Of prime interest, the spin-spin coupling schemes allowed for an intimate study of the solution behavior of the Tl-containing POPs via a combination of P and Tl NMR, including the stoichiometry of the major fragments of . Moreover, biological studies demonstrated the antitumor and antiviral activity of and , which were validated to be as efficient as -platinum against human melanoma and acute promyelocytic leukemia cells. Furthermore, and exerted inhibitory activity against two herpetic viruses, HSV-2 and HCMV, in a dose-response manner.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.inorgchem.3c01530 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!